Switch to
View more

Gufic Biosciences Ltd

GUFICBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,200 cr, stock is ranked 696
High RiskStock is 3.09x as volatile as Nifty
227.005.85 (-2.51%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,200 cr, stock is ranked 696
High RiskStock is 3.09x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
22.96
PB RatioPB Ratio
12.69
Dividend YieldDiv. Yield
0.04%
Sector PESector PE
32.89
Sector PBSector PB
4.57
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Gufic Biosciences Limited manufactures pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Formulations, Bulk Drugs and Consumer.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2019202020212022354.94384.63491.43782.2621.9422.7044.2395.84
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Re-appointment 
Announced OnJun 28, 2022

Gufic Biosciences Limited has informed the Exchange about re-appointment of Rabi Sahoo as Independent Director of the company | Download

Gufic Biosciences Limited has informed the Exchange about re-appointment of Rabi Sahoo as Independent Director of the company | Download

Credit Rating 
Announced OnJun 24, 2022

Gufic Biosciences Limited has informed the Exchange about Upgrade of Credit Rating | Download

Gufic Biosciences Limited has informed the Exchange about Upgrade of Credit Rating | Download

Cash Dividend 
Ex. DateSep 9, 2021

Final • Div/Share: ₹ 0.1

See all events